Literature DB >> 24797181

A higher number of infused CD34(+) cells has a positive impact on the clinical outcome after related PBSC transplantation.

K Maie1, S Fuji2, K Tajima2, M Tatsuno2, S Yamagata2, N Takahashi2, R Ueda2, H Hashimoto2, K Takano2, Y Inoue2, A Ito2, Y Hayashi2, K Okinaka2, S Kurosawa2, S-W Kim2, R Tanosaki3, Y Heike2, T Yamashita2, T Fukuda2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24797181     DOI： 10.1038/bmt.2014.94

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  The impact of CD34+ cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling.

Authors:  T Stiehl; A D Ho; A Marciniak-Czochra
Journal:  Bone Marrow Transplant       Date:  2013-09-23       Impact factor: 5.483

2.  Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.

Authors:  N Dhédin; T Prébet; R Peffault De Latour; S Katsahian; M Kuentz; N Piard; D Réa; F Norol; J P Jouet; J A Ribeil; R Tabrizi; B Rio; B Lioure; P Tiberghien; J H Bourhis; A Sirvent; P Bordigoni; D Blaise; M Michallet; J P Vernant
Journal:  Bone Marrow Transplant       Date:  2012-05-21       Impact factor: 5.483

3.  Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation.

Authors:  Henrique Bittencourt; Vanderson Rocha; Sylvie Chevret; Gérard Socié; Hélène Espérou; Agnès Devergie; Liliane Dal Cortivo; Jean-Pierre Marolleau; Federico Garnier; Patricia Ribaud; Eliane Gluckman
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

4.  CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies.

Authors:  E Bahçeci; E J Read; S Leitman; R Childs; C Dunbar; N S Young; A J Barrett
Journal:  Br J Haematol       Date:  2000-02       Impact factor: 6.998

5.  Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Susan F Leitman; Paolo Anderlini; John P Klein; Mary M Horowitz; John P Miller; Roberta J King; Dennis L Confer
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

6.  Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia.

Authors:  M K Ishaqi; S Afzal; A Dupuis; J Doyle; A Gassas
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

7.  Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates.

Authors:  Ryotaro Nakamura; Nademanee Auayporn; David D Smith; Joycelynne Palmer; Joel Y Sun; Jeffrey Schriber; Vinod Pullarkat; Pablo Parker; Roberto Rodriguez; Anthony Stein; Joseph Rosenthal; Shirong Wang; Chatchada Karanas; Karl Gaal; David Senitzer; Stephen J Forman
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

8.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

9.  Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.

Authors:  M Mohty; K Bilger; E Jourdan; M Kuentz; M Michallet; J H Bourhis; N Milpied; L Sutton; J P Jouet; M Attal; P Bordigoni; J Y Cahn; A Sadoun; N Ifrah; D Guyotat; C Faucher; N Fegueux; J Reiffers; D Maraninchi; D Blaise
Journal:  Leukemia       Date:  2003-05       Impact factor: 11.528
  9 in total
  1 in total

1.  Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation.

Authors:  Matthias Kollek; Gesina Voigt; Christian Molnar; Fabronia Murad; Daniela Bertele; Christopher Felix Krombholz; Sheila Bohler; Verena Labi; Stefan Schiller; Mirjam Kunze; Stephan Geley; Charlotte M Niemeyer; Ana Garcia-Saez; Miriam Erlacher
Journal:  J Exp Med       Date:  2017-09-07       Impact factor: 14.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.